Report from the 2022 American Society of Hematology Annual Meeting — Benign Hematology

Presenters at the 2022 American Society of Hematology (ASH) annual meeting, held December 10–13 in New Orleans, reported the latest research in hematology. NEJM Group was on hand to cover the meeting. Here, NEJM Journal Watch Oncology and Hematology reports on some of the key findings in benign hematology, and Associate Editor Dr. Anjali A. Sharathkumar provides her clinical perspective. Abstracts can be found on the ASH meeting site.

Racial and Socioeconomic Inequities Apparent in PE Treatment and Mortality

Among hospitalized adults with pulmonary embolism (PE), nonwhite patients and those of lower socioeconomic status are less likely to receive advanced treatments — and are more likely to die in the hospital — according to a retrospective a…